PXN and neoplasm: In contrast, AZD0424 produced potent inhibition of migration of human tumour cells, with evidence of inhibition of phosphorylation of the Src kinase substrate paxillin, suggesting anti-tumour effects may be due to inhibition of Src-mediated adhesion and motility signalling pathways.